Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 114

Similar articles for PubMed (Select 22265821)

1.

Matrix metalloproteinase-3 is activated by HtrA2/Omi in dopaminergic cells: relevance to Parkinson's disease.

Shin EJ, Kim EM, Lee JA, Rhim H, Hwang O.

Neurochem Int. 2012 Feb;60(3):249-56. doi: 10.1016/j.neuint.2012.01.001. Epub 2012 Jan 11.

PMID:
22265821
2.

Translocation of the serine protease Omi/HtrA2 from mitochondria into the cytosol upon seizure-induced hippocampal injury in the neonatal rat brain.

Rami A, Kim M, Niquet J.

Neurochem Res. 2010 Dec;35(12):2199-207. doi: 10.1007/s11064-010-0322-0. Epub 2010 Dec 4.

PMID:
21132459
3.

The serine protease Omi/HtrA2 is involved in XIAP cleavage and in neuronal cell death following focal cerebral ischemia/reperfusion.

Althaus J, Siegelin MD, Dehghani F, Cilenti L, Zervos AS, Rami A.

Neurochem Int. 2007 Jan;50(1):172-80. Epub 2006 Sep 15.

PMID:
16978742
4.

Variations in the protein level of Omi/HtrA2 in the heart of aged rats may contribute to the increased susceptibility of cardiomyocytes to ischemia/reperfusion injury and cell death : Omi/HtrA2 and aged heart injury.

Wang K, Zhang J, Liu J, Tian J, Wu Y, Wang X, Quan L, Xu H, Wang W, Liu H.

Age (Dordr). 2013 Jun;35(3):733-46. doi: 10.1007/s11357-012-9406-x. Epub 2012 Apr 26.

5.

Omi/HtrA2 promotes cell death by binding and degrading the anti-apoptotic protein ped/pea-15.

Trencia A, Fiory F, Maitan MA, Vito P, Barbagallo AP, Perfetti A, Miele C, Ungaro P, Oriente F, Cilenti L, Zervos AS, Formisano P, Beguinot F.

J Biol Chem. 2004 Nov 5;279(45):46566-72. Epub 2004 Aug 24.

6.

Enhanced HtrA2/Omi expression in oxidative injury to retinal pigment epithelial cells and murine models of neurodegeneration.

Ding X, Patel M, Shen D, Herzlich AA, Cao X, Villasmil R, Klupsch K, Tuo J, Downward J, Chan CC.

Invest Ophthalmol Vis Sci. 2009 Oct;50(10):4957-66. doi: 10.1167/iovs.09-3381. Epub 2009 May 14.

7.

Inhibitor of apoptosis proteins are substrates for the mitochondrial serine protease Omi/HtrA2.

Srinivasula SM, Gupta S, Datta P, Zhang Z, Hegde R, Cheong N, Fernandes-Alnemri T, Alnemri ES.

J Biol Chem. 2003 Aug 22;278(34):31469-72. Epub 2003 Jun 30.

8.

A novel intracellular role of matrix metalloproteinase-3 during apoptosis of dopaminergic cells.

Choi DH, Kim EM, Son HJ, Joh TH, Kim YS, Kim D, Flint Beal M, Hwang O.

J Neurochem. 2008 Jul;106(1):405-15. doi: 10.1111/j.1471-4159.2008.05399.x. Epub 2008 Jul 1.

PMID:
18397366
9.

Mitochondrial protease Omi/HtrA2 enhances caspase activation through multiple pathways.

Suzuki Y, Takahashi-Niki K, Akagi T, Hashikawa T, Takahashi R.

Cell Death Differ. 2004 Feb;11(2):208-16.

10.

Modulation of the Omi/HtrA2 signaling pathway after transient focal cerebral ischemia in mouse brains that overexpress SOD1.

Saito A, Hayashi T, Okuno S, Nishi T, Chan PH.

Brain Res Mol Brain Res. 2004 Aug 23;127(1-2):89-95.

PMID:
15306124
11.

Omi / HtrA2 is relevant to the selective vulnerability of striatal neurons in Huntington's disease.

Inagaki R, Tagawa K, Qi ML, Enokido Y, Ito H, Tamura T, Shimizu S, Oyanagi K, Arai N, Kanazawa I, Wanker EE, Okazawa H.

Eur J Neurosci. 2008 Jul;28(1):30-40. doi: 10.1111/j.1460-9568.2008.06323.x.

PMID:
18662332
12.

Role of Omi/HtrA2 in apoptotic cell death after myocardial ischemia and reperfusion.

Liu HR, Gao E, Hu A, Tao L, Qu Y, Most P, Koch WJ, Christopher TA, Lopez BL, Alnemri ES, Zervos AS, Ma XL.

Circulation. 2005 Jan 4;111(1):90-6. Epub 2004 Dec 20.

13.

Akt attenuation of the serine protease activity of HtrA2/Omi through phosphorylation of serine 212.

Yang L, Sun M, Sun XM, Cheng GZ, Nicosia SV, Cheng JQ.

J Biol Chem. 2007 Apr 13;282(15):10981-7. Epub 2007 Feb 20.

14.

Binding specificity and regulation of the serine protease and PDZ domains of HtrA2/Omi.

Martins LM, Turk BE, Cowling V, Borg A, Jarrell ET, Cantley LC, Downward J.

J Biol Chem. 2003 Dec 5;278(49):49417-27. Epub 2003 Sep 25.

15.

The mitochondrial serine protease HtrA2/Omi cleaves RIP1 during apoptosis of Ba/F3 cells induced by growth factor withdrawal.

Vande Walle L, Wirawan E, Lamkanfi M, Festjens N, Verspurten J, Saelens X, Vanden Berghe T, Vandenabeele P.

Cell Res. 2010 Apr;20(4):421-33. doi: 10.1038/cr.2010.18. Epub 2010 Feb 2.

PMID:
20125124
16.

Doxycycline is neuroprotective against nigral dopaminergic degeneration by a dual mechanism involving MMP-3.

Cho Y, Son HJ, Kim EM, Choi JH, Kim ST, Ji IJ, Choi DH, Joh TH, Kim YS, Hwang O.

Neurotox Res. 2009 Nov;16(4):361-71. doi: 10.1007/s12640-009-9078-1. Epub 2009 Jul 7.

PMID:
19582534
17.

Involvment of cytosolic and mitochondrial GSK-3beta in mitochondrial dysfunction and neuronal cell death of MPTP/MPP-treated neurons.

Petit-Paitel A, Brau F, Cazareth J, Chabry J.

PLoS One. 2009;4(5):e5491. doi: 10.1371/journal.pone.0005491. Epub 2009 May 11.

18.

Upregulation of mitochondrial protease HtrA2/Omi contributes to manganese-induced neuronal apoptosis in rat brain striatum.

Jiang JK, Ma X, Wu QY, Qian WB, Wang N, Shi SS, Han JL, Zhao JY, Jiang SY, Wan CH.

Neuroscience. 2014 May 30;268:169-79. doi: 10.1016/j.neuroscience.2014.03.003. Epub 2014 Mar 19.

PMID:
24657776
19.

[Effects of Omi/HtrA2 on expression of anti-apoptotic protein PED/PEA-15 and apoptosis of prostate cancer cell line PC-3].

Hu XY, Chen XC, Zhu ZH, Chen CH, Zeng FQ, Lu GC.

Ai Zheng. 2006 Jun;25(6):677-82. Chinese.

PMID:
16764760
20.

Specific protein interaction of human Pag with Omi/HtrA2 and the activation of the protease activity of Omi/HtrA2.

Hong SK, Cha MK, Kim IH.

Free Radic Biol Med. 2006 Jan 15;40(2):275-84. Epub 2005 Oct 12.

PMID:
16413409
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk